Results 141 to 150 of about 707,954 (344)
Economic Analysis of Welfare Economics, Morality and the Law [PDF]
This paper contains the chapters on welfare economics, morality, and the law from a general, forthcoming book, Foundations of Economic Analysis of Law (Harvard University Press, 2003).
Steven Shavell
core
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
The fictionalization of morality police in Saudi novel: a new historicist approach
The morality police have always inspired different, often conflicting, feelings in Saudi society. While many have supported the morality police, others saw their old privileges as problematic.
Mohammed Albalawi
doaj +1 more source
The Evolutionary Roots of Morality in Theological Perspective
Theological ethics can interpret the relation between evolution and morality in at least three ways. The reductionist approach holds that morality emerges because it is adaptive.
doaj +2 more sources
The politics of end‐of‐life decision‐making: computerised decision‐support tools, physicians’ jurisdiction and morality [PDF]
Beth Jennings
openalex +1 more source
Does morality require sameness?: a response and question to Jennifer Frey [PDF]
HUMBER VAN STRAALEN
openalex +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source

